🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are urged to message these accounts privately for source information, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of rapid British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Experts Express Worries

Nevertheless, doctors and chemists have cautions that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.

Some professionals said the demand for the experimental drug could be connected to the increasing price of licensed weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate medicines, advertising, and consumer regulations, potentially leading to fines, legal action or imprisonment.

Platform Reaction and Content Removal

Based on the social media company, the platform has taken down problematic content and banned related hashtags and query recommendations. The company stated it was dedicated to keeping the service safe and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Investigations also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly brings up channels with numerous of users, populated with photos of slimming results, positive testimonials and detailed instructions for preparing or administering at residence.

After minutes of entering one community, a vendor shared WhatsApp details, where the majority of transactions occur. The seller provided an guidebook and guaranteed delivery within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about body mass, medical conditions or previous experience.

Item Information and Costs

Within these communities, posts display dark colored parcels with postal service stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When questioned how long a injector should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for Telegram stated it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they can’t verify. Although the science behind this drug is sound, these digital versions may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.

Her staff has already encountered patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may expose users to potentially serious medical dangers”.